AIRLINK 71.69 Decreased By ▼ -2.41 (-3.25%)
BOP 5.00 No Change ▼ 0.00 (0%)
CNERGY 4.39 Increased By ▲ 0.05 (1.15%)
DFML 28.55 Decreased By ▼ -0.99 (-3.35%)
DGKC 82.40 Decreased By ▼ -1.15 (-1.38%)
FCCL 21.95 Decreased By ▼ -0.48 (-2.14%)
FFBL 34.15 Decreased By ▼ -0.75 (-2.15%)
FFL 10.08 Increased By ▲ 0.21 (2.13%)
GGL 10.12 Increased By ▲ 0.12 (1.2%)
HBL 113.00 Increased By ▲ 1.00 (0.89%)
HUBC 140.50 Increased By ▲ 2.81 (2.04%)
HUMNL 8.03 Increased By ▲ 1.05 (15.04%)
KEL 4.38 Decreased By ▼ -0.02 (-0.45%)
KOSM 4.50 Decreased By ▼ -0.09 (-1.96%)
MLCF 38.01 Decreased By ▼ -0.54 (-1.4%)
OGDC 134.69 Decreased By ▼ -1.91 (-1.4%)
PAEL 26.62 Increased By ▲ 1.48 (5.89%)
PIAA 25.40 Decreased By ▼ -1.11 (-4.19%)
PIBTL 6.55 Decreased By ▼ -0.10 (-1.5%)
PPL 121.95 Decreased By ▼ -3.45 (-2.75%)
PRL 27.73 Decreased By ▼ -0.48 (-1.7%)
PTC 13.80 Decreased By ▼ -0.50 (-3.5%)
SEARL 54.89 Increased By ▲ 0.29 (0.53%)
SNGP 69.70 Decreased By ▼ -1.50 (-2.11%)
SSGC 10.40 Decreased By ▼ -0.10 (-0.95%)
TELE 8.50 Decreased By ▼ -0.02 (-0.23%)
TPLP 10.95 Increased By ▲ 0.01 (0.09%)
TRG 60.90 Increased By ▲ 0.20 (0.33%)
UNITY 25.22 Decreased By ▼ -0.11 (-0.43%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
BR100 7,619 Decreased By -45.8 (-0.6%)
BR30 24,969 Decreased By -56.1 (-0.22%)
KSE100 72,761 Decreased By -3 (-0%)
KSE30 23,625 Decreased By -150.3 (-0.63%)

imageAndrew Calabrese, a third grader was just three years old when his pancreas gave up, rendering him with the dreaded Type-1 diabetes for life.

However, his parents Heidi and Jason didn’t gave up hope, and Jason, a software engineer by profession, developed a device that could help regulate his son’s insulin levels i.e. a robotic pancreas.

According to Wall Street Journal, Jason was able to make an artificial pancreas for his son, using the OpenAPS (Open Artificial Pancreas System), which is a free online project in order to make the APS technology widely available, so that lives could be saved and the burden of Type 1 diabetes can be reduced.

As per Oddity Central, the APS was developed by a 27 year old Dana Lewis in December 2014, a Type 1 diabetic himself. The OpenAPS provides “a safety-focused reference design, a toolset, and an open source reference implementation that can be used by any individual – or any medical device manufacturer.”

imageFollowing the instructions, Jason learnt how to use an old insulin pump to control blood glucose (BG) levels, automatically, both overnight and in between meals. The software engineer added a Continuous Glucose Monitor (CGM) to provide BG data to the pump, and command it to adjust the temporary basal rates accordingly.

Andrew finally began using OpenAPS to keep in check his insulin levels, after doctor’s approval. “OpenAPS is there when I can’t be,” Jason said. “It’s cut the time Andrew spends below 80 mg/dL in half.”

“Diabetes is dangerous anyway. Insulin is dangerous. I think what we are doing is actually improving that and lowering the risk,” he added. However, Jason admitted that this solution is still subjected to pump or tubing failures, and that the insulin dosing for meals is still needed to be done manually.

Copyright Business Recorder, 2016

Comments

Comments are closed.